Skip to content
10-Q

Quarterly Report

CORTRONIX BIOMEDICAL ADVANCEMENT TECHNOLOGIES INC.

0001594062-14-000049

← back to feed
Filed
Mar 3, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Feb 28, 2014 349.5M sh
Shares Diluted Q1 2014 · Nov 30, 2013 294.55M sh
Operating Cash Flow Q1 2014 · Nov 30, 2013 −$640
Operating Cash Flow Q1 2014 · Nov 30, 2013 −$291.66K
Stockholders Equity Q1 2014 · Nov 30, 2013 −$1.09M
Stockholders Equity Q1 2014 · Aug 31, 2013 −$1.05M
Current Liabilities Q1 2014 · Nov 30, 2013 $1.17M
Current Liabilities Q1 2014 · Aug 31, 2013 $1.14M
Current Assets Q1 2014 · Nov 30, 2013 $60.38K
Current Assets Q1 2014 · Aug 31, 2013 $61.02K
Total Assets Q1 2014 · Nov 30, 2013 $83.07K
Total Assets Q1 2014 · Aug 31, 2013 $85.37K
Sga Expense Q1 2014 · Nov 30, 2013 $12.34K
Sga Expense Q1 2014 · Nov 30, 2013 $131.06K
Net Income Q1 2014 · Nov 30, 2013 −$5.04M
Net Income Q1 2014 · Nov 30, 2013 −$5.49M
Operating Income Q1 2014 · Nov 30, 2013 −$4.26M
Operating Income Q1 2014 · Nov 30, 2013 −$4.63M
Cash And Equivalents Q1 2014 · Aug 31, 2013 $640
Cash And Equivalents Q1 2014 · Aug 2, 2012 $640